What the analyst said
Evercore ISI analyst Kirk Materne lowered the price target on Oracle (NYSE: ORCL) to $185.00 (from $200.00) while maintaining an Outperform rating.
“Quarter & FY26 Revenue Acceleration Help Offset F3Q Revenue Shortfall Bottom line: Oracle served up something for both bulls and bears last night as while revenue/EPS came in a bit shy of forecasts, the company blew away expectations for RPO ($130bn vs. ~$105bn est) and guided to 15% revenue growth in FY26.
From a bookings perspective, there were a few larger deals that helped drive the RPO beat, but the company noted that OCI demand is broad based and continues to outstrip capacity.
In addition to guiding FY26 revenue to 15% growth, the company is forecasting revenue growth could accelerate to 20% by FY27 – and this does NOT include any contributions from Stargate.
Finally, it should be noted that the guidance for F4Q Cloud revenue is 26-28% in c/c (not 24-28%), which indicates acceleration vs. +25% this quarter. Of course, the offset to the strong OCI growth is the fact that OCI margins, especially AI-related revenue, will be a drag on GM’s and operating margins will come down in FY26 as a result.
Given that we had previously lowered our op. margin target to 42.5% (it comes down another 60bps), our FY26 EPS estimate only comes down by $0.07 as our revenue estimate moves higher (now 13% vs. 11.7%).
However, we expect that much of the Street will need to adjust op. margin expectations this morning and this could offset some of the enthusiasm related to the acceleration in bookings/RPO. At these levels, we believe the pros (accelerating revenue/OCI growth) outweigh the cons (mixed F3Q and lower op. margins/FCF) and with Street estimates likely to be reset at levels where they can move higher over the remainder of CY25, we believe the risk/reward skews to the upside for those that can take a view out to the summer/fall.
Given the broader pullback in the market, we are tweaking our PT to $185 or ~25x CY26 EPS. In terms of other takeaways from the call, we would highlight: (1) The F3Q revenue shortfall was largely the result of some component shortages which impacted capacity and some license revenue (~$100mn) shifting around.
Capacity issues will linger into F4Q but cloud is expected to accelerate in F4Q; 2) RPO growth was aided by a couple larger deals, but this was overall a very balanced bookings quarter. cRPO grew by 17% in F3Q vs. +21% in F2Q; (3) Capex was pulled forward a bit in F3Q (~$6bn) and will normalize towards ~$4bn in F4Q; (4) OCI consumption revenue was up 57%, and GPU consumption revenue is 3.5x the size of last year’s; and (5) Cloud database services were up 28% and now has a $2.3bn revenue runrate, and Autonomous consumption revenue is up 42%.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
ORCL trades at $101. The 23 analysts who set a target in the last 3 months range from $155 to $400, with a median of $240. This $185 target is 23% below the median.
Since the note ORCL has moved −32% (from $149). The 12-month window closed on March 11, 2026.
Track record
This call✓ Target reached on June 12, 2025, 3 months after the note.
Firm track recordEvercore: 79% of its 38 targets at least a year old were reached within 12 months (#12 of 29 firms); on Oracle, 3 of 3. Accuracy ranking →
Evercore on Oracle
Evercore price targets on Oracle
6 calls from March 11, 2025 to June 24, 2026. The target went from $185 to $245 (+32%). The rating stayed Buy.





